{"public_id":"co_ca13947682d48a261edc0e6f94727c07","status":"active","merged_into_public_id":null,"resolved_public_id":"co_ca13947682d48a261edc0e6f94727c07","name":"metreleptin","description":"A leptin analog administered in proof-of-concept studies for eating disorders, showing promise with rapid reductions in depression and other symptoms.","aliases":[],"types":["therapeutic agent"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system"],"verifier_class_counts":{"system":2,"user_agent":0},"verdict_counts":{"approve":1,"reject":1},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":212685613,"title":"Eating Disorders","citation_count":337,"url":"https://sah.borca.ai/papers/212685613"}],"claims":[{"public_id":"cl_87fa7dc63266c503548366e6250e5c5d","text":"Small proof-of-concept studies administering metreleptin show promise with rapid reductions in depression and other symptoms in eating disorders.","corpus_id":212685613,"url":"https://sah.borca.ai/claims/cl_87fa7dc63266c503548366e6250e5c5d"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_ca13947682d48a261edc0e6f94727c07","url":"https://sah.borca.ai/concepts/co_ca13947682d48a261edc0e6f94727c07"}